A Novel Frame Shift Mutation in the GHRH Receptor Gene in Familial Isolated GHD eficiency: Early Occurrence of Anterior Pituitary Hypoplasia
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Authors: Shohreh, Rugia; Sherafat-Kazemzadeh, Rosa; Jee, Youn Hee; Blitz, Ari; Salvatori, Roberto
Abstract
Background: Mutations in the genes encoding for GHRH receptor (GHRHR) and GH (GH1) are the most common cause of familial isolated GH deficiency (IGHD). GHRHR mutations are often associated with anterior pituitary hypoplasia (APH), but this has been reported almost exclusively in children older than 8 yr. We analyzed the GHRHR and measured pituitary size in a consanguineous family with the father and three of the five siblings with IGHD. Objective: The aim of the study was to find the mutated gene in a family with severe IGHD. Methods: We sequenced the whole GHRHR coding regions and the intron-exon boundaries from peripheral DNA of the index patient. After identifying the novel mutation, we sequenced the region of interest in the other members of the family. We measured the anterior pituitary volume from magnetic resonance imaging (MRI). Results: The father and the three affected children were homozygous for a new frame-shift mutation in the coding sequence of exon 4 (corresponding to the extracellular domain of the receptor) (c.391delG) that places the downstream sequence out of frame. The mother and two unaffected siblings were heterozygous for the mutation. Two of the affected children had MRI evidence of APH before reaching 6 yr of age. Conclusions: We describe a new mutation in the GHRHR in a family with IGHD. The presence of frank APH before age 6 yr shows that MRI-evident reduced pituitary size can be present in GHRHR mutations even in children younger than 8 yr of age. (J Clin Endocrinol Metab 96: 2982-2986, 2011)
Variants in FtsJ RNA 2 '-O-Methyltransferase 3 and Growth Hormone 1 are associated with small body size and a dental anomaly in dogs
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Authors: Abrams, Sydney R.; Hawks, Alexandra L.; Evans, Jacquelyn M.; Famula, Thomas R.; Mahaffey, Mary; Johnson, Gary S.; Mason, Jennifer M.; Clark, Leigh Anne
Abstract
Domesticated dogs show unparalleled diversity in body size across breeds, but within breeds variation is limited by selective breed-ing. Many heritable diseases of dogs are found among breeds of similar sizes, suggesting that as in humans, alleles governing growth have pleiotropic effects. Here, we conducted independent genomewide association studies in the small Shetland Sheepdog breed and discovered a locus on chromosome 9 that is associated with a dental abnormality called maxillary canine-tooth mesioversion (MCM) (P = 1.53 x 10(-7)) as well as two body size traits: height (P = 1.67 x 10(-5)) and weight (P = 1.16 x 10(-7)). Using whole-genome resequencing data, we identified variants in two proximal genes: FTSJ3, encoding an RNA methyltransferase, and GH1, encoding growth hormone. A substitution in FTSJ3 and a splice donor insertion in GH1 are strongly associated with MCM and reduced body size in Shetland Sheepdogs. We demonstrated in vitro that the GH1 variant leads to exon 3 skipping, predicting a mutant protein known to cause human pituitary dwarfism. Statistical modeling, however, indicates that the FTSJ3 variant is the stronger predictor of MCM and that each derived allele reduces body size by about 1 inch and 5 pounds. In a survey of 224 breeds, both FTSJ3 and GH1 variants are frequent among very small "toy" breeds and absent from larger breeds. Our findings indicate that a chromosome 9 locus harboring tightly linked variants in FTSJ3 and GH1 reduces growth in the Shetland Sheepdog and toy breed dogs and confers risk for MCM through vertical pleiotropy.